Literature DB >> 29076540

Osteogenic differentiation in dedifferentiated liposarcoma: a study of 36 cases in comparison to the cases without ossification.

Kyoko Yamashita1, Kenichi Kohashi2, Yuichi Yamada2, Takeaki Ishii2, Yoshihiro Nishida3, Hiroshi Urakawa3, Ichiro Ito4, Mitsuru Takahashi5, Takeshi Inoue6, Masafumi Ito7, Yuuki Ohara1, Yoshinao Oda2, Shinya Toyokuni1.   

Abstract

AIMS: Ossification is found occasionally in dedifferentiated liposarcoma (DDLPS). The aims of this study were to elucidate whether the formed bone tissue is usually produced by tumour cells or by reactive non-neoplastic cells, and to reveal the clinicopathological characteristics of DDLPS with ossification. METHODS AND
RESULTS: We examined 36 cases of ossified DDLPS by comparing them to 31 cases of non-ossified DDLPS. MDM2 amplification was confirmed in osteocytes and/or osteoblastic cells in all but one ossified DDLPS cases (27 of 28) using fluorescence in-situ hybridisation, although the morphological impression of ossification appeared to be mainly metaplastic (27 of 36) or high-grade osteosarcoma-like (six of 36). The bone tissue was often formed predominantly at the periphery of the DDLPS area near the well-differentiated liposarcoma component (18 of 36), and an organised structure such as bone marrow-like differentiation was not uncommon (12 of 36). According to a modified French Fédération Nationale des Centers de Lutte Contre le Cancer (FNCLCC) grading system, ossified DDLPS tended to be lower grade than non-ossified DDLPS (mean grade: 1.88 and 2.15, respectively). Ossification in DDLPS was associated significantly with shorter local recurrence-free survival by multivariate analysis (P = 0.02347), but metaplastic-appearing ossification tended to be associated with longer overall survival (P = 0.1400).
CONCLUSIONS: The bone tissue formed in DDLPS was mainly neoplastic regardless of its morphology and maturity, which highlighted the osteogenic differentiation of the tumour cells. DDLPS patients with osteogenic differentiation tended to suffer from earlier local recurrences, which did not necessarily lead to poor life outcomes.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  MDM2 amplification; dedifferentiated liposarcoma; osteogenic differentiation

Mesh:

Year:  2017        PMID: 29076540     DOI: 10.1111/his.13421

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

Review 1.  What is new about the molecular genetics in matrix-producing soft tissue tumors? -The contributions to pathogenetic understanding and diagnostic classification.

Authors:  Yu-Chien Kao; Jen-Chieh Lee; Hsuan-Ying Huang
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

2.  BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance.

Authors:  Yingyi Kong; Shinya Akatsuka; Yashiro Motooka; Hao Zheng; Zhen Cheng; Yukihiro Shiraki; Tomoji Mashimo; Tatsuhiko Imaoka; Shinya Toyokuni
Journal:  Redox Biol       Date:  2022-05-28       Impact factor: 10.787

3.  Sarcomas of fat and bone: a case report.

Authors:  Miriam Beate Honnicke; Lars Tharun; Malte Maria Sieren; Jörg Barkhausen
Journal:  Discov Oncol       Date:  2022-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.